Impax Looks To Duck Endo's $100M Suit Over Drug Licensing
Generic-drug maker Impax Laboratories asked a New Jersey federal judge Monday to toss Endo Pharmaceuticals' $100 million lawsuit alleging it is refusing to negotiate royalty payments on a generic version of...To view the full article, register now.
Already a subscriber? Click here to view full article